In an attempt to contain costs, 27 Medicaid programs have implemented patient-level
payment limits for medications, but the effects of these restrictions on quality of care, costs …

Objective: To examine the impact of 2 cost-containment efforts in prescription benefits in
successive years that included changes in copayment and coverage levels, expanded …

Prescription drug expenditures totaled more than $55 billion in 1990 and by the year 2000
are projected to rise above $125 billion (Burner, Waldo, and McKusick, 1992). They made …

BACKGROUND: In 2006, pharmacies began offering select generic prescription drugs at
discount prices (eg, 4fora30-daysupply)throughnonmembershipandmembershippro….Aspartofthecontractinmembershipgenericdr …

Copayment for prescription drugs in a Medicaid drug program is an increasingly popular
mechanism to finance dispensing fee increases. There is, however, reason to expect such a …

Expenditures for specialty drugs account for more than 25 percent of total US drug spending
and have been increasing at more than 13 percent annually. We examined insurers' role in …

We Started the Managed Care Outcomes Project (MCOP) in order to examine the impact of
various cost-containment practices on pa tients' use of health care services in managed care …

This is the second article in a 2-part series that examines the economic impact of several
different strategies used to control costs in third party programmes. This article investigates 5 …

Background: Most insurers in the US have implemented incentive-based formularies that
rely on out-of-pocket costs to influence prescription drug utilization. Medicare Part D plans …

Michigan's Medicaid program implemented four cost containment policies—preferred drug
lists, joint and multistate purchasing arrangements, and maximum allowable cost—during …